Show simple item record

dc.creatorBix, Gregory J.
dc.date.accessioned2019-06-17T17:09:46Z
dc.date.available2019-06-17T17:09:46Z
dc.date.issued2015-07-07
dc.identifier.urihttps://hdl.handle.net/1969.1/177107
dc.description.abstractThe disclosed invention relates to the use of perlecan domain V (DV) for the treatment of stroke, traumatic brain injury (TBI) or spinal cord injuries (SCI). In certain embodiments, fusion proteins of DV can be used for the treatment of stroke, TBI or SCI. DV is also referred to as endorepellin in the art. This application also provides compositions and combination therapies for the treatment of stroke, TCI and/or SCI. Another aspect of the invention provides methods of restoring motor function in subjects having neurological damage arising from a stroke, TBI or SCI.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titlePerlecan domain V protects, repairs and restores ischemic brain stroke injury and motor functionen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeTHE Texas A&M UNIVERSITY SYSTEM
dc.identifier.patentapplicationnumber13/175518
dc.date.filed2011-07-01
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryA61K 38/2006
dc.subject.cpcprimaryA61K 31/727
dc.subject.cpcprimaryA61K 38/177
dc.subject.cpcprimaryA61K 45/06
dc.subject.cpcprimaryA61K 2300/00
dc.subject.cpcprimaryC07K 16/2842
dc.subject.cpcprimaryC07K 2317/75
dc.subject.cpcprimaryC07K 2317/76
dc.subject.cpcprimaryC07K 2317/34


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record